Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023

Loading...
Loading...

Upgrades

According to Tigress Financial, the prior rating for Walmart Inc WMT was changed from Neutral to Buy. In the third quarter, Walmart showed an EPS of $1.50, compared to $1.45 from the year-ago quarter. The current stock performance of Walmart shows a 52-week-high of $160.77 and a 52-week-low of $117.27. Moreover, at the end of the last trading period, the closing price was at $142.34.

For Norfolk Southern Corp NSC, Deutsche Bank upgraded the previous rating of Hold to Buy. For the fourth quarter, Norfolk Southern had an EPS of $3.42, compared to year-ago quarter EPS of $3.12. At the moment, the stock has a 52-week-high of $291.55 and a 52-week-low of $203.65. Norfolk Southern closed at $242.97 at the end of the last trading period.

For FibroGen Inc FGEN, Raymond James upgraded the previous rating of Market Perform to Outperform. In the third quarter, FibroGen showed an EPS of $0.98, compared to $0.54 from the year-ago quarter. The stock has a 52-week-high of $21.30 and a 52-week-low of $7.81. At the end of the last trading period, FibroGen closed at $20.65.

See all analyst ratings upgrades.

Downgrades

Compass Point downgraded the previous rating for Blue Foundry Bancorp BLFY from Buy to Neutral. Blue Foundry earned $0.02 in the fourth quarter, compared to $0.65 in the year-ago quarter. The current stock performance of Blue Foundry shows a 52-week-high of $14.89 and a 52-week-low of $11.01. Moreover, at the end of the last trading period, the closing price was at $12.40.

According to Northcoast Research, the prior rating for ManpowerGroup Inc MAN was changed from Buy to Neutral. ManpowerGroup earned $2.21 in the third quarter, compared to $1.93 in the year-ago quarter. The stock has a 52-week-high of $115.54 and a 52-week-low of $64.00. At the end of the last trading period, ManpowerGroup closed at $88.61.

According to Keefe, Bruyette & Woods, the prior rating for Popular Inc BPOP was changed from Outperform to Market Perform. Popular earned $2.62 in the fourth quarter, compared to $2.58 in the year-ago quarter. The current stock performance of Popular shows a 52-week-high of $95.28 and a 52-week-low of $62.55. Moreover, at the end of the last trading period, the closing price was at $66.16.

According to Janney Montgomery Scott, the prior rating for LendingClub Corp LC was changed from Buy to Neutral. LendingClub earned $0.19 in the fourth quarter, compared to $0.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of $23.84 and a 52-week-low of $8.23. LendingClub closed at $10.34 at the end of the last trading period.

For Magenta Therapeutics Inc MGTA, Cowen & Co. downgraded the previous rating of Outperform to Market Perform. For the third quarter, Magenta Therapeutics had an EPS of $0.27, compared to year-ago quarter EPS of $0.30. At the moment, the stock has a 52-week-high of $3.62 and a 52-week-low of $0.32. Magenta Therapeutics closed at $0.49 at the end of the last trading period.

For Prosperity Bancshares Inc PB, Janney Montgomery Scott downgraded the previous rating of Buy to Neutral. Prosperity Bancshares earned $1.51 in the fourth quarter, compared to $1.38 in the year-ago quarter. The current stock performance of Prosperity Bancshares shows a 52-week-high of $77.93 and a 52-week-low of $64.69. Moreover, at the end of the last trading period, the closing price was at $75.58.

According to Deutsche Bank, the prior rating for Union Pacific Corp UNP was changed from Buy to Hold. Union Pacific earned $2.67 in the fourth quarter, compared to $2.66 in the year-ago quarter. The stock has a 52-week-high of $278.94 and a 52-week-low of $183.70. At the end of the last trading period, Union Pacific closed at $200.12.

According to Janney Montgomery Scott, the prior rating for UMB Financial Corp UMBF was changed from Buy to Neutral. UMB Financial earned $2.07 in the fourth quarter, compared to $1.62 in the year-ago quarter. The current stock performance of UMB Financial shows a 52-week-high of $106.08 and a 52-week-low of $76.97. Moreover, at the end of the last trading period, the closing price was at $87.99.

B of A Securities downgraded the previous rating for NextEra Energy Inc NEE from Buy to Neutral. For the fourth quarter, NextEra Energy had an EPS of $0.51, compared to year-ago quarter EPS of $0.41. The stock has a 52-week-high of $91.35 and a 52-week-low of $67.22. At the end of the last trading period, NextEra Energy closed at $76.59.

According to Wedbush, the prior rating for Magenta Therapeutics Inc MGTA was changed from Outperform to Neutral. Magenta Therapeutics earned $0.27 in the third quarter, compared to $0.30 in the year-ago quarter. At the moment, the stock has a 52-week-high of $3.62 and a 52-week-low of $0.32. Magenta Therapeutics closed at $0.49 at the end of the last trading period.

For Carter's Inc CRI, Wedbush downgraded the previous rating of Outperform to Neutral. For the third quarter, Carter's had an EPS of $1.67, compared to year-ago quarter EPS of $1.93. At the moment, the stock has a 52-week-high of $100.07 and a 52-week-low of $62.66. Carter's closed at $81.53 at the end of the last trading period.

According to Deutsche Bank, the prior rating for Nasdaq Inc NDAQ was changed from Buy to Hold. In the fourth quarter, Nasdaq showed an EPS of $0.64, compared to $0.64 from the year-ago quarter. The current stock performance of Nasdaq shows a 52-week-high of $69.22 and a 52-week-low of $46.77. Moreover, at the end of the last trading period, the closing price was at $58.30.

For Viasat Inc VSAT, William Blair downgraded the previous rating of Outperform to Market Perform. Viasat earned $0.18 in the second quarter, compared to $0.34 in the year-ago quarter. The current stock performance of Viasat shows a 52-week-high of $52.72 and a 52-week-low of $25.38. Moreover, at the end of the last trading period, the closing price was at $37.36.

JP Morgan downgraded the previous rating for EVgo Inc EVGO from Overweight to Neutral. For the third quarter, EVgo had an EPS of $0.19, compared to year-ago quarter EPS of $0.09. At the moment, the stock has a 52-week-high of $14.23 and a 52-week-low of $3.64. EVgo closed at $5.97 at the end of the last trading period.

Stifel downgraded the previous rating for TTM Technologies Inc TTMI from Buy to Hold. For the third quarter, TTM Technologies had an EPS of $0.56, compared to year-ago quarter EPS of $0.34. The current stock performance of TTM Technologies shows a 52-week-high of $17.48 and a 52-week-low of $9.76. Moreover, at the end of the last trading period, the closing price was at $16.73.

According to Wells Fargo, the prior rating for Hyatt Hotels Corp H was changed from Overweight to Equal-Weight. For the third quarter, Hyatt Hotels had an EPS of $0.64, compared to year-ago quarter EPS of $2.31. The stock has a 52-week-high of $113.19 and a 52-week-low of $70.12. At the end of the last trading period, Hyatt Hotels closed at $112.11.

UBS downgraded the previous rating for Pfizer Inc PFE from Buy to Neutral. In the third quarter, Pfizer showed an EPS of $1.78, compared to $1.34 from the year-ago quarter. The stock has a 52-week-high of $56.32 and a 52-week-low of $41.45. At the end of the last trading period, Pfizer closed at $45.07.

Loading...
Loading...

See all analyst ratings downgrades.

Initiations

Guggenheim initiated coverage on Dyne Therapeutics Inc DYN with a Buy rating. The price target for Dyne Therapeutics is set to $33.00. In the third quarter, Dyne Therapeutics showed an EPS of $0.80, compared to $0.83 from the year-ago quarter. At the moment, the stock has a 52-week-high of $15.63 and a 52-week-low of $4.30. Dyne Therapeutics closed at $13.51 at the end of the last trading period.

Credit Suisse initiated coverage on Exelixis Inc EXEL with an Outperform rating. The price target for Exelixis is set to $29.00. Exelixis earned $0.31 in the third quarter, compared to $0.20 in the year-ago quarter. The stock has a 52-week-high of $23.40 and a 52-week-low of $14.87. At the end of the last trading period, Exelixis closed at $17.33.

Citigroup initiated coverage on Match Group Inc MTCH with a Neutral rating. The price target for Match Group is set to $55.00. In the third quarter, Match Group showed an EPS of $0.44, compared to $0.43 from the year-ago quarter. At the moment, the stock has a 52-week-high of $121.49 and a 52-week-low of $38.64. Match Group closed at $50.54 at the end of the last trading period.

With a Buy rating, Chardan Capital initiated coverage on Coya Therapeutics Inc COYA. The price target seems to have been set at $9.00 for Coya Therapeutics. The stock has a 52-week-high of $5.67 and a 52-week-low of $4.50. At the end of the last trading period, Coya Therapeutics closed at $4.78.

With a Buy rating, HC Wainwright & Co. initiated coverage on TC BioPharm (Holdings) PLC TCBP. The price target seems to have been set at $9.00 for TC BioPharm (Holdings). NoneThe stock has a 52-week-high of $175.00 and a 52-week-low of $2.81. At the end of the last trading period, TC BioPharm (Holdings) closed at $4.05.

Wolfe Research initiated coverage on DexCom Inc DXCM with an Outperform rating. The price target for DexCom is set to $121.00. For the third quarter, DexCom had an EPS of $0.28, compared to year-ago quarter EPS of $0.22. At the moment, the stock has a 52-week-high of $539.06 and a 52-week-low of $67.11. DexCom closed at $104.00 at the end of the last trading period.

For Insulet Corp PODD, Wolfe Research initiated coverage, by setting the current rating at Peer Perform. Insulet earned $0.45 in the third quarter, compared to $0.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $317.93 and a 52-week-low of $181.00. Insulet closed at $289.70 at the end of the last trading period.

For Tandem Diabetes Care Inc TNDM, Wolfe Research initiated coverage, by setting the current rating at Peer Perform. For the third quarter, Tandem Diabetes Care had an EPS of $0.27, compared to year-ago quarter EPS of $0.09. The current stock performance of Tandem Diabetes Care shows a 52-week-high of $124.90 and a 52-week-low of $33.52. Moreover, at the end of the last trading period, the closing price was at $39.89.

Piper Sandler initiated coverage on Albemarle Corp ALB with an Overweight rating. The price target for Albemarle is set to $310.00. Albemarle earned $7.50 in the third quarter, compared to $1.05 in the year-ago quarter. The stock has a 52-week-high of $334.55 and a 52-week-low of $169.93. At the end of the last trading period, Albemarle closed at $270.98.

Cantor Fitzgerald initiated coverage on JFrog Ltd FROG with an Overweight rating. The price target for JFrog is set to $29.00. For the third quarter, JFrog had an EPS of $0.02, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of $28.18 and a 52-week-low of $16.36. At the end of the last trading period, JFrog closed at $25.26.

Cantor Fitzgerald initiated coverage on Datadog Inc DDOG with an Overweight rating. The price target for Datadog is set to $95.00. For the third quarter, Datadog had an EPS of $0.23, compared to year-ago quarter EPS of $0.13. The current stock performance of Datadog shows a 52-week-high of $184.70 and a 52-week-low of $61.34. Moreover, at the end of the last trading period, the closing price was at $70.75.

With an Outperform rating, RBC Capital initiated coverage on V2X Inc VVX. The price target seems to have been set at $55.00 for V2X. The stock has a 52-week-high of $45.53 and a 52-week-low of $29.55. At the end of the last trading period, V2X closed at $42.57.

For Roblox Corp RBLX, Oppenheimer initiated coverage, by setting the current rating at Perform. In the third quarter, Roblox showed an EPS of $0.50, compared to $0.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $73.71 and a 52-week-low of $21.65. Roblox closed at $35.70 at the end of the last trading period.

See all analyst ratings initiations.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...